Acute Coronary SyndromeSyndromeAngina, UnstableCoronary AngiographyMyocardial InfarctionCoronary VesselsCoronary Artery DiseasePlatelet Aggregation InhibitorsAngioplasty, Balloon, CoronaryCoronary DiseaseAcute DiseaseGene ExpressionChest PainCoronary ThrombosisCoronary CirculationTreatment OutcomeBiological MarkersRisk FactorsElectrocardiographyHemorrhageCoronary StenosisPlatelet Glycoprotein GPIIb-IIIa ComplexProspective StudiesCoronary Artery BypassTroponin TAngina PectorisSleep Apnea, ObstructivePercutaneous Coronary InterventionMyocardial RevascularizationRisk AssessmentPulmonary Disease, Chronic ObstructiveTroponin ITime FactorsPredictive Value of TestsMyocardial IschemiaPrognosisPurinergic P2Y Receptor AntagonistsAspirinFollow-Up StudiesPlaque, AtheroscleroticEnoxaparinCreatine Kinase, MB FormLung Diseases, ObstructiveCoronary Care UnitsAnticoagulantsC-Reactive ProteinUltrasonography, InterventionalCoronary VasospasmHeptanoic AcidsHospitalizationStentsOocyte RetrievalFibrinolytic AgentsAngina, StableHydroxymethylglutaryl-CoA Reductase InhibitorsRetrospective StudiesSeverity of Illness IndexThiophenesRecurrenceCardiovascular AgentsRupture, SpontaneousRegistriesHirudinsAcetanilidesCoronary AneurysmHospital MortalityRandomized Controlled Trials as TopicPyrrolesThrombosisHeparinCoronary RestenosisKaplan-Meier EstimateMultivariate AnalysisDouble-Blind MethodJaundice, ObstructiveChi-Square DistributionCoronary OcclusionAngioscopyDrug Therapy, CombinationTriageCardiac CatheterizationCase-Control StudiesHirudin TherapyProportional Hazards ModelsSensitivity and SpecificityCohort StudiesCreatine KinaseThrombolytic TherapyPravastatinLogistic ModelsIncidencePlatelet ActivationMetabolic Syndrome XROC CurveNatriuretic Peptide, BrainAlbaniaSecondary PreventionVascular CalcificationImmunoglobulin Fab FragmentsAge Factors